Han Lab News


'You won’t live a long life' and 4 other things people get wrong about this chronic disease

May Han, assistant professor of neurology and neurological sciences, provides comment in this article that debunks common misconception about multiple sclerosis. 


Steady strides in multiple-sclerosis therapeutics research

A team of researchers led by May Han, assistant professor of neurology and neurological sciences, have discovered a clue why some patients fail to respond to Gilenya, a therapy used to treat multiple sclerosis. 


Found: Potential new way to predict some multiple-sclerosis patients’ disease course, drug response

Stanford neurologist May Han, MD, who specializes in MS, encounters questions like these from her patients on a daily basis. MS is an autoimmune disease of the brain and spinal cord that causes paralysis, blindness and other disabling symptoms. Over a million people, most of them young adults in the prime of life, suffer from MS worldwide.


Post-doctoral position available in the Han Lab.
Please contact Dr. May Han

Neurology in the News